The Trump administration, after dismantling the US Agency for International Development (USAID) last year, is now offering substantial financial aid to African countries to bolster their healthcare systems and combat diseases. However, these new agreements come with conditions that have led to resistance from some governments. The first significant deal, a $2.5 billion agreement with Kenya, was delayed due to legal challenges but was eventually approved. The US is contributing $1.6 billion, while Kenya has pledged $850 million over five years. This approach marks a shift from traditional donor-NGO relationships to direct partnerships with national governments, aiming to reduce dependency and overhead costs. The US has also withdrawn from the World Health Organization, criticizing its management and transparency. The new bilateral deals prioritize US pharmaceutical and medical firms, aligning with American strategic interests.
QUESTION: How might the shift from global cooperation to direct bilateral agreements impact the effectiveness of healthcare aid in African countries?
Why some African nations are turning down Trump aid money
